OTC · DLTNF
Delta 9 Cannabis Inc.
$0.01-$0.00 (-1.95%)
Delta 9 Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.33% below the high.
Loading market information…
OTC · EPWCF · USD
Stock price, earnings
Quote as of Jun 4, 2025, 12:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Empower Clinics Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Empower Clinics Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Empower Clinics Inc. functions as a comprehensive healthcare provider, delivering integrated wellness services that address both physical and mental well-being. Patients receive care through various channels, including digital platforms, telemedicine consultations, and advanced medical diagnostics laboratories, catering to populations across the United States and Canada. The company is actively developing a network, with 33 clinics in its pipeline, located in the Canadian provinces of Alberta, British Columbia, and New Brunswick. Additionally, Empower Clinics has formed a strategic partnership with SoLVBL Solutions Inc. to create secure data management solutions for its diagnostic testing processes. The firm's corporate headquarters are situated in Vancouver, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:29 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01-$0.00 (-1.95%)
Delta 9 Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.33% below the high.
$0.02$0.00 (0.0%)
Lumiera Health Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.68$0.00 (0.0%)
ATI Physical Therapy, Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.6% below the high.
$0.08$0.00 (0.0%)
Eve & Co Incorporated’s quoted price sits in the lower half of its reported 52-week range, 36.31% below the high.
$0.07$0.00 (0.0%)
Awakn Life Sciences Corp.’s quoted price sits in the lower half of its reported 52-week range, 51.27% below the high.
$0.00+$0.00 (+45.0%)
GABY Inc.: Healthcare · Medical - Pharmaceuticals.
$0.01$0.00 (0.0%)
Pideka Group Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.04-$0.00 (-2.67%)
CBD Global Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.37% below the high.
